JP2006511620A5 - - Google Patents

Download PDF

Info

Publication number
JP2006511620A5
JP2006511620A5 JP2005508486A JP2005508486A JP2006511620A5 JP 2006511620 A5 JP2006511620 A5 JP 2006511620A5 JP 2005508486 A JP2005508486 A JP 2005508486A JP 2005508486 A JP2005508486 A JP 2005508486A JP 2006511620 A5 JP2006511620 A5 JP 2006511620A5
Authority
JP
Japan
Prior art keywords
antibody
pharmaceutical formulation
preparation according
pharmaceutical
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005508486A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006511620A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038809 external-priority patent/WO2004052397A1/en
Publication of JP2006511620A publication Critical patent/JP2006511620A/ja
Publication of JP2006511620A5 publication Critical patent/JP2006511620A5/ja
Pending legal-status Critical Current

Links

JP2005508486A 2002-12-05 2003-12-05 抗cd3抗体による潰瘍性大腸炎の処置方法 Pending JP2006511620A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43164902P 2002-12-05 2002-12-05
US45018303P 2003-02-25 2003-02-25
PCT/US2003/038809 WO2004052397A1 (en) 2002-12-05 2003-12-05 Methods of treatment of ulcerative colitis with anti-cd3 antibodies

Publications (2)

Publication Number Publication Date
JP2006511620A JP2006511620A (ja) 2006-04-06
JP2006511620A5 true JP2006511620A5 (cg-RX-API-DMAC7.html) 2007-01-25

Family

ID=32511592

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005508486A Pending JP2006511620A (ja) 2002-12-05 2003-12-05 抗cd3抗体による潰瘍性大腸炎の処置方法

Country Status (7)

Country Link
US (1) US20040253237A1 (cg-RX-API-DMAC7.html)
EP (1) EP1567192A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006511620A (cg-RX-API-DMAC7.html)
KR (1) KR20050091713A (cg-RX-API-DMAC7.html)
AU (1) AU2003298015A1 (cg-RX-API-DMAC7.html)
CA (1) CA2508264A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004052397A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7883703B2 (en) 2003-11-14 2011-02-08 The Brigham And Women's Hospital, Inc. Methods of modulating immunity
SG188175A1 (en) 2004-06-03 2013-03-28 Novimmune Sa Anti-cd3 antibodies and methods of use thereof
WO2007026742A1 (ja) * 2005-08-30 2007-03-08 Ajinomoto Co., Inc. 大腸デリバリー型炎症性大腸疾患治療薬
AU2006291005A1 (en) * 2005-09-12 2007-03-22 Novimmune S.A. Anti-CD3 antibody formulations
US20090258001A1 (en) * 2006-06-06 2009-10-15 Paul Ponath Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
AU2012201443B2 (en) * 2006-06-06 2014-04-03 Glaxo Group Limited Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
TWI736437B (zh) 2010-11-30 2021-08-11 日商中外製藥股份有限公司 細胞傷害誘導治療劑
EP3371311B1 (en) 2015-11-06 2021-07-21 Orionis Biosciences BV Bi-functional chimeric proteins and uses thereof
CN109071632B (zh) 2016-02-05 2022-12-30 奥里尼斯生物科学私人有限公司 靶向性治疗剂及其用途
KR102379464B1 (ko) 2016-06-20 2022-03-29 키맵 리미티드 항-pd-l1 항체
CA3045944A1 (en) 2016-12-07 2018-06-14 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
EP3576765B1 (en) 2017-02-06 2025-07-16 Orionis Biosciences, Inc. Targeted engineered interferon and uses thereof
CA3054632A1 (en) 2017-03-30 2018-10-04 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
US20230041197A1 (en) 2018-06-20 2023-02-09 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
US12227565B2 (en) 2018-06-20 2025-02-18 Biora Therapeutics, Inc. Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine
CN113348011B (zh) 2018-11-19 2023-04-18 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
CN115916818A (zh) 2019-12-11 2023-04-04 库利南肿瘤股份有限公司 抗cd19抗体和多特异性结合蛋白
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
CN118562007A (zh) * 2019-12-19 2024-08-30 苏州方德门达新药开发有限公司 工程改造的t细胞、其制备及应用
WO2023174925A1 (en) 2022-03-14 2023-09-21 Novimmune Sa Bispecific gpc3xcd28 and gpc3xcd3 antibodies and their combination for targeted killing of gpc3 positive malignant cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932214A (en) * 1994-08-11 1999-08-03 Biogen, Inc. Treatment for inflammatory bowel disease with VLA-4 blockers
US5834597A (en) * 1996-05-20 1998-11-10 Protein Design Labs, Inc. Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
DE19905012A1 (de) * 1999-02-08 2000-08-10 Gsf Forschungszentrum Umwelt Arzneimittel enthaltend Anti-CD3- und Anti-Fcgamma-R-Antikörper zur begleitenden Behandlung bei Organtransplantationen
US20040131614A1 (en) * 2002-07-19 2004-07-08 Abbott Biotechnology Ltd. Treatment of pulmonary disorders using TNFalpha inhibitor

Similar Documents

Publication Publication Date Title
JP7293122B2 (ja) 補体が媒介する疾患および障害を処置するための方法
TWI306458B (en) Humanized antibodies that recognize beta amyloid peptide
CN111068062B (zh) 治疗白介素-6相关疾病的方法
JP2020536888A5 (cg-RX-API-DMAC7.html)
JP2020537644A5 (cg-RX-API-DMAC7.html)
JP2021502961A5 (cg-RX-API-DMAC7.html)
JP2014114288A5 (cg-RX-API-DMAC7.html)
JP2021519305A5 (cg-RX-API-DMAC7.html)
JPWO2020059847A5 (cg-RX-API-DMAC7.html)
JP2022521956A5 (cg-RX-API-DMAC7.html)
JP2013519690A5 (cg-RX-API-DMAC7.html)
JP2024540275A5 (cg-RX-API-DMAC7.html)
JP2021531255A (ja) 非古典的hla−iおよびネオアンチゲンを含む複合体を標的とする抗体、およびその使用方法
EP3634478A1 (en) Methods of suppressing microglial activation
JP2023516925A5 (cg-RX-API-DMAC7.html)
US20240109977A1 (en) Anti-cd38 antibodies and their uses
US20230227555A1 (en) Cd-3 antibodies for the treatment of coronavirus
JP2023506779A5 (cg-RX-API-DMAC7.html)
JP2023546504A5 (cg-RX-API-DMAC7.html)
CA3199806A1 (en) Methods of reducing tau in human subjects
JP2023550311A5 (cg-RX-API-DMAC7.html)
JP2024507986A (ja) 抗体関連型移植拒絶反応の治療に使用するための抗cd38抗体
JP2025504383A5 (cg-RX-API-DMAC7.html)
EP3937978A1 (en) A method for immunosuppression
JP2008531719A5 (cg-RX-API-DMAC7.html)